Table 4 Admittance to specialised palliative care in relation to region of residence, age, sex, metastatic cancer, cancer treatment and year for death for patients with pancreatic cancer (N = 5851)
From: Regional and age differences in specialised palliative care for patients with pancreatic cancer
| Â | Â | Admittance to SPCa |
|---|---|---|
| Â | Â | OR (95%CI) |
Region of residence |  | p = < 0.001 |
Capital | 1 | |
Zealand | 1.42 (1.20–1.69) | |
Southern | 0.74 (0.64–0.86) | |
Central | 1.04 (0.89–1.21) | |
North | 2.03 (1.67–2.48) | |
Age (year) |  | p = < 0.001 |
< 60 | 2.54 (2.05–3.15) | |
60–69 | 1.41 (1.19–1.66) | |
70–79 | 1.29 (1.11–1.50) | |
80+ | 1 | |
Sex |  | p = < 0.001 |
Male | 0.71 (0.64–0.79) | |
Female | 1 | |
Metastatic cancer |  | p = 0.004 |
Yes No | 1.18 (1.06–1.32) 1 | |
Anticancer treatment (from diagnosis to death) |  | p = < 0.001 |
Yes | 1.81 (1.61–2.03) | |
No | 1 | |
Year of death |  | p = < 0.001 |
2011b | 0.51 (0.37–0.70) | |
2012 | 0.62 (0.51–0.77) | |
2013 | 0.81 (0.66–1.00) | |
2014 | 0.77 (0.63–0.94) | |
2015 | 0.93 (0.76–1.14) | |
2016 | 1.14 (0.92–1.40) | |
2017 | 0.96 (0.78–1.17) | |
2018 | 1 |